Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 6:10 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 337–360 of 2,674 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: Stanford University Clear all

Conditions: Melanoma, Brain Metastases
Interventions: Ipilimumab, Nivolumab + Relatlimab FDC; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Injury; Nerve, Peripheral, Multiple, Chronic Post-Procedural Pain, Total Knee Arthroplasty, Surgery, Knee Injuries, Knee Pain Chronic, Postoperative Pain, Chronic Postoperative Pain
Interventions: SPRINT® Peripheral Nerve Stimulation (PNS) System (510k Cleared); Device
Lead sponsor: Stanford University; Other
Eligibility: 21 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Redwood City, California

Conditions: HIV/AIDS
Interventions: The BRIDGES Project Intervention; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: San Diego, California

Conditions: Awe
Interventions: Virtual Reality, Control; Behavioral · Other
Lead sponsor: Stanford University; Other
Eligibility: 6 Years to 99 Years
Enrollment: 202 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Stanford, California

Conditions: Pancreatic Cancer
Interventions: Oxaliplatin, Irinotecan, Leucovorin, 5FU, Stereotactic Body Radiotherapy (SBRT); Drug · Radiation
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2022
U.S. locations: 7
States / cities: Los Angeles, California • San Francisco, California • Stanford, California + 4 more

Conditions: Obesity
Interventions: Not listed
Lead sponsor: Stanford University; Other
Eligibility: 2 Years to 4 Years
Enrollment: 130 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Stanford, California

Conditions: Autism Spectrum Disorder, Autism
Interventions: Intensive Center-Based Pivotal Response Treatment (PRT-C); Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 2 Years to 3 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Stanford, California

Conditions: Pancreas Cancer
Interventions: 89Zr-panitumumab; Drug
Lead sponsor: Stanford University; Other
Eligibility: 19 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Stanford, California

Conditions: Breast Neoplasms
Interventions: endocrine therapy alone without radiotherapy; Other
Lead sponsor: University of Michigan Rogel Cancer Center; Other
Eligibility: 50 Years to 69 Years · Female only
Enrollment: 202 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2028
U.S. locations: 13
States / cities: Stanford, California • New Haven, Connecticut • Maywood, Illinois + 10 more

Conditions: Gastroesophageal Reflux
Interventions: Fexofenadine, Placebo - Cap; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Redwood City, California

Conditions: Leukemia, Lymphocytic, Chronic
Interventions: high dose chemotherapy then autologous hematopoietic cell transplant, ablative allogeneic hematopoietic cell transplant; Procedure
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1996 – 2010
U.S. locations: 1
States / cities: Stanford, California

Conditions: Congenital Cataract
Interventions: Contact lens correction of aphakia, Intraocular lens implantation; Device
Lead sponsor: Stanford University; Other
Eligibility: 28 Days to 210 Days
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2020
U.S. locations: 13
States / cities: Palo Alto, California • Miami, Florida • Atlanta, Georgia + 10 more

Conditions: Liver Cancer
Interventions: Not listed
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 573 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2024
U.S. locations: 1
States / cities: Stanford, California

Conditions: Acute Respiratory Distress Syndrome
Interventions: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells; Biological
Lead sponsor: Michael A. Matthay; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 4
States / cities: San Francisco, California • Stanford, California • Boston, Massachusetts + 1 more

Conditions: Major Depressive Disorder, Insomnia
Interventions: Escitalopram, CBTI, CTRL; Drug · Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Delirium, Postoperative Delirium, Cognitive Impairment
Interventions: Not listed
Lead sponsor: Stanford University; Other
Eligibility: 65 Years and older
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Bladder Cancer, Bladder (Urothelial, Transitional Cell) Cancer, Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive), Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy), Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable
Interventions: Pazopanib (GW786034), Paclitaxel; Drug
Lead sponsor: Sandy Srinivas; Other
Eligibility: 18 Years and older
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 2
States / cities: Stanford, California • Detroit, Michigan

Conditions: Blood Cancer, Leukemia
Interventions: Cyclosporine, Anti-thymocyte globulin (ATG), Mycophenolate mofetil (MMF), Filgrastim, Total Lymphoid Irradiation (TLI); Drug · Radiation
Lead sponsor: Stanford University; Other
Eligibility: 50 Years to 70 Years
Enrollment: 303 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2016
U.S. locations: 1
States / cities: Stanford, California

Conditions: Healthy Adult, Exercise
Interventions: Time-driven dosing; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 25 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Stanford, California

Conditions: Acute Kidney Injury
Interventions: Aminophylline, Placebo; Drug
Lead sponsor: Stanford University; Other
Eligibility: 1 Day to 18 Years
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Osteoarthritis, Knee
Interventions: Gait retraining; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Stanford, California

Conditions: Breast Cancer, Metastatic Breast Cancer
Interventions: Gemcitabine, Paclitaxel, Bevacizumab; Drug
Lead sponsor: George Albert Fisher; Other
Eligibility: 18 Years and older · Female only
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Stanford, California

Conditions: Fear, PTSD, Panic Disorder
Interventions: Amygdala recording and stimulation using Neuropace RNS, Behavioral tasks; Device · Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Head and Neck Cancer, Carcinoma, Squamous Cell, Head and Neck Cancers
Interventions: PET scan; Radiation
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2005
U.S. locations: 1
States / cities: Stanford, California

Search by objective public record fields.

Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases

Using Peripheral Nerve Stimulation (PNS) to Treat Chronic Post-surgical Pain (CPSP) After Knee Surgery

The BRIDGES Project: Bridging Resources to Engage Women in Integrated HIV Care and Support Services

Awe Inducing Elements in Virtual Reality Applications: A Prospective Study of Hospitalized Children

Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer

Prevention of Childhood Obesity

A Center Based Study of Pivotal Response Treatment for Preschoolers With Autism

Pilot Study of 89-Zr Panitumumab in Pancreas Cancer

The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)

Fexofenadine Use in Gastroesophageal Reflux Symptoms

Transplantation for Patients With Chronic Lymphocytic Leukemia

Infant Aphakia Treatment Study (IATS)

Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma

Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome

Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression Outcome

Stanford PIPRA Validation Study in an Elderly Orthopedic Population

Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer

Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies

Diurnal Strength Variation

Aminophylline to Prevent Acute Kidney Injury in Children After Cardiac Surgery

Gait Retraining to Reduce Knee Osteoarthritis Pain

Phase 2 Study of Gemzar, Taxol & Avastin Combination as 1st Line Treatment for Metastatic Breast Cancer

Investigations of Amygdala Function Using Neurophysiological Recording and Stimulation

Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation